ST
VNDA icon

Spot Trading’s Vanda Pharmaceuticals VNDA Stock Holding History

Spot Trading’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-107
Closed -$1K – 4016
2015
Q4 		$1K Hold
107
– – ﹤0.01% 3528
2015
Q3 		$1K Buy
+107
New +$1.31K ﹤0.01% 3843
2015
Q1 		– Sell
-2,771
Closed -$40K – 4346
2014
Q4 		$40K Buy
+2,771
New +$32.8K ﹤0.01% 3492
2014
Q3 		– Sell
-9,235
Closed -$149K – 4734
2014
Q2 		$149K Sell
9,235
-26,675
-74% -$355K ﹤0.01% 3517
2014
Q1 		$584K Buy
35,910
+12,544
+54% +$178K ﹤0.01% 2427
2013
Q4 		$290K Buy
+23,366
New +$235K ﹤0.01% 2815

Other funds holding VNDA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's VNDA Position: Q1 2016 in Review

Spot Trading sold out of Vanda Pharmaceuticals (VNDA) in Q1 2016, closing a stake of 107 shares — an estimated $1K sold.

Spot Trading first reported a position in VNDA in Q4 2013 and held it in 6 quarters. The position peaked at $584K in Q1 2014. 116 funds tracked by Wall St. Rank hold VNDA as of Q1 2016.

  • Spot Trading reported no remaining Vanda Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 107 Vanda Pharmaceuticals shares in Q1 2016, an estimated $1K.
  • Spot Trading first reported a position in Vanda Pharmaceuticals in Q4 2013 and held it in 6 quarters.
  • Spot Trading's Vanda Pharmaceuticals position peaked at $584K in Q1 2014.
  • 116 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.